Gilead Releases New Data On HIV Prevention
Gilead Sciences, Inc. has developed the first, and only, twice-yearly HIV prevention injection. New data was released on October 8th at the HIV Research for Prevention Conference in Lima, Peru on their medicine, lenacapavir. According to their trial, phase …